Dr. Kyrtania Pather

Kyrtania Pather is a biomedical researcher whose work centers on the interplay between hormone-dependent breast cancer, coagulation pathways, and platelet–tumor cell interactions. Her studies explore how endocrine therapies such as tamoxifen and anastrozole influence hypercoagulation, tumor phenotype, and metastatic potential, with particular attention to estrogen receptor subtypes and epithelial–mesenchymal transition.

Through in vitro and ex vivo models integrating whole blood, platelet-rich plasma, and cancer cell lines, her research elucidates mechanisms linking hormone therapy to thromboembolic risk. Proteomic and ultrastructural analyses feature prominently in her work, highlighting tumor adaptability, secretome alterations, and immunomodulatory effects that contribute to pro-tumorigenic and hypercoagulatory states.

In addition, she has contributed to scholarship on antimicrobial resistance education, examining gamification as a strategy to improve stewardship and prescribing behaviors. Based on a focused but developing body of publications, her expertise reflects a translational approach bridging cancer biology, thrombosis research, and innovative health education.